Literature DB >> 10623730

Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.

E A Gustafson1, R F Schinazi, J D Fingeroth.   

Abstract

Human herpesvirus 8 (HHV8) open reading frame (ORF) 21 is predicted to encode a protein similar to the thymidine kinase (TK) enzyme of other herpesviruses. Expressed in mammalian cells, ORF 21 was found to have low TK activity, based on poor growth in media containing hypoxanthine-aminopterin-thymidine (HAT) and low incorporation of [(3)H]thymidine into high-molecular-weight DNA. Kinetic analysis using HHV8 TK as a purified glutathione S-transferase (GST) fusion protein showed that the enzyme has a comparatively high K(m) for thymidine (dThd) of approximately 33.2 microM. Nearly 50% of the phosphorylated product of the reaction with dThd was thymidylate. This monophosphate kinase activity was more pronounced with 3'-azido-3'-deoxythymidine (AZT), in which 78% of the reaction product was AZT diphosphate. Thymidine analogs competitively inhibited dThd phosphorylation by HHV8 TK, while 2'-deoxyguanosine, 2'-deoxyadenosine, 2'-deoxycytidine, and corresponding analogs did not. Further competition experiments revealed that the nucleoside analog ganciclovir (GCV), at up to 1,000-fold molar excess, could not significantly inhibit dThd phosphorylation by the enzyme. In support of these data, 143B TK(-) cells expressing HHV8 TK phosphorylated GCV very poorly and were not susceptible to GCV toxicity compared to parental cells. Phosphorylation of [(3)H]GCV by a purified GST-HHV8 TK fusion protein was not detected by high-pressure liquid chromatography analysis. Structural features of HHV8 TK substrate recognition were investigated. Therapeutic implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623730      PMCID: PMC111588          DOI: 10.1128/jvi.74.2.684-692.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

Authors:  W Zhong; H Wang; B Herndier; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.

Authors:  M J Glesby; D R Hoover; S Weng; N M Graham; J P Phair; R Detels; M Ho; A J Saah
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

3.  Substrate specificity of Epstein-Barr virus thymidine kinase.

Authors:  P P Tung; W C Summers
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  AIDS-associated Kaposi's sarcoma.

Authors:  J L Jones; D L Hanson; S Y Chu; J W Ward; H W Jaffe
Journal:  Science       Date:  1995-02-24       Impact factor: 47.728

5.  Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus.

Authors:  M M Mansuri; M J Hitchcock; R A Buroker; C L Bregman; I Ghazzouli; J V Desiderio; J E Starrett; R Z Sterzycki; J C Martin
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  The A+T-rich genome of Herpesvirus saimiri contains a highly conserved gene for thymidylate synthase.

Authors:  R W Honess; W Bodemer; K R Cameron; H H Niller; B Fleckenstein; R E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection.

Authors:  P S Moore; Y Chang
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

8.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

9.  Interactions of azidothymidine triphosphate with the cellular DNA polymerases alpha, delta, and epsilon and with DNA primase.

Authors:  W Nickel; S Austermann; G Bialek; F Grosse
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

10.  Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.

Authors:  J C Lin; Z X Zhang; M C Smith; K Biron; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

View more
  34 in total

1.  Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion.

Authors:  Michael B Gill; Jo-Ellen Murphy; Joyce D Fingeroth
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles.

Authors:  Michael B Gill; Jeffery L Kutok; Joyce D Fingeroth
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

Review 3.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

4.  KSHV-TK: thymidine kinase or tyrosine kinase?

Authors:  Michael Lagunoff
Journal:  EMBO J       Date:  2015-01-08       Impact factor: 11.598

5.  Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.

Authors:  Natacha Coen; Sophie Duraffour; Dimitri Topalis; Robert Snoeck; Graciela Andrei
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

6.  High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Authors:  Thomas S Uldrick; Mark N Polizzotto; Karen Aleman; Deirdre O'Mahony; Kathleen M Wyvill; Victoria Wang; Vickie Marshall; Stefania Pittaluga; Seth M Steinberg; Giovanna Tosato; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

7.  Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues.

Authors:  S M Moore; J S Cannon; Y C Tanhehco; F M Hamzeh; R F Ambinder
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

8.  Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.

Authors:  Motoki Kurokawa; Subrata K Ghosh; Juan Carlos Ramos; Abdul M Mian; Ngoc L Toomey; Lisa Cabral; Denise Whitby; Glen N Barber; Dirk P Dittmer; William J Harrington
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

9.  Human herpesvirus 8 gene encodes a functional thymidylate synthase.

Authors:  Gábor Gáspár; Erik De Clercq; Johan Neyts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.

Authors:  Huong Q Nguyen; Amalia S Magaret; Mari M Kitahata; Stephen E Van Rompaey; Anna Wald; Corey Casper
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.